Posts tagged: subsidiary
Pfizer subsidiary extends tender offer to acquire King to January 21, 2011
Pfizer Inc. today announced that its wholly-owned subsidiary, Parker Tennessee Corp., has extended the expiration date of its tender offer for all outstanding shares of common stock of King Pharmaceuticals, Inc. for $14.25 per share, net to the seller in cash, without interest thereon and subject to any required withholding ...
SunOpta subsidiary closes acquisition of Edner
SunOpta Inc. today announced that its indirect wholly-owned subsidiary SunOpta Fruit Group Inc. has completed the previously announced acquisition of the assets and business of Edner of Nevada, Inc..
Silicon Biosystems’ newly formed subsidiary to commercialize DEPArray technology platform
Silicon Biosystems, S.p.A., a provider of specialized molecular and cell biology technology, today announced that it has formed a U.S. subsidiary operation, Silicon Biosystems, Inc., to be headquartered in San Diego, California. The newly formed business will focus on commercial operations and the development of the North American research and ...
Wolters Kluwer Health subsidiary to acquire Pharmacy OneSource
Wolters Kluwer Health today announced that one of its wholly- owned subsidiaries has entered into an agreement to acquire Pharmacy OneSource, a leading healthcare Software-as-a-Service (SaaS) provider that helps hospitals manage the complex challenges of patient safety, compliance and efficiency. The transaction will allow Wolters Kluwer Health to extend its ...
Community Health Systems amends existing credit agreement with subsidiary
Community Health Systems, Inc. today announced that on November 5, 2010, it and its wholly-owned subsidiary CHS/Community Health Systems, Inc. entered into an amendment and restatement (the "Amendment") of their existing credit agreement, dated as of July 25, 2007 (as amended and restated, the "Credit Agreement").
Granville subsidiary signs commitment letter to refinance construction debt
Granville Pacific Capital Corporation announces that a subsidiary of the Company, Evergreen Cottages Corp, has signed a commitment letter to refinance the Company's construction debt.
Valeant subsidiary to acquire leading skin care brands in Australia
Valeant Pharmaceuticals International, Inc. announced today that its subsidiary, Biovail Laboratories International SRL (BLS), has agreed to acquire several privately–owned pharmacy skin care brands in Australia. The leading brands, including well-established local brands such as Hamilton's Suncare and Hamilton's Skin Therapy, are ranked #2 in suncare in the Australian ...
IntegraGen to open subsidiary in Cambridge, Massachusetts
IntegraGen, Inc., a French biotechnology company dedicated to gene discovery and the development of molecular diagnostic products and services, announced today that it is expanding its operations by opening a U.S. subsidiary headquartered in Cambridge, Massachusetts that will support the company's clinical research initiatives focused on the early identification of ...
China Medical Technologies Announces its Subsidiary, GP Medical, Ranked Sixth in Deloitte Technology Fast 50 China 2010 Program
BEIJING, Oct. 22 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED ), a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that its subsidiary, Beijing GP Medical Technologies Co., Ltd. ("GP Medical"), has been ranked sixth in the Deloitte Technology Fast 50 China 2010 program ...
K-V Pharmaceutical Company Announces Establishment of New Generic Marketing Subsidiary and Senior Executive Appointment
ST. LOUIS, Oct. 20 /- K-V Pharmaceutical Company (NYSE: KVa/KVb) today announced the establishment of a new generic marketing subsidiary, Nesher Pharmaceuticals, Inc. and the appointment of Mark Hartman as its President. Greg Divis, Interim President and Chief Executive Officer of the Company, stated, "Mark brings recognized depth ...
MultiCell’s Majority Owned Subsidiary Acquires Bioabsorbable Interventional Cardiology Stent Assets
WOONSOCKET, R.I., Oct. 19 /- MultiCell Technologies, Inc. (OTC Bulletin Board: MCET ) and its majority owned subsidiary, Xenogenics Corporation, are pleased to announce the acquisition of the Ideal™ BioStent assets by Xenogenics Corporation from investment funds managed by Western Technology Investment and Silicon Valley Bank. Xenogenics Corporation ...